Phase II study of i.v. vinflunine as second line in patients with metastatic breast cancer after anthracycline-taxane failure

被引：0
|
作者：
Fumoleau, P
Campone, M
Vorobiof, D
Casado, M
Ruff, P
Kei, SK
Cortes-Funes, H
Khalfallah, S
Caroff, I
Colin, C
机构：
[1] Ctr George Francois Leclerc, Dijon, France
[2] CRLC Nantes Atlantique, Ctr Rene Gauducheau, St Herblain, France
[3] Saridton Oncol Ctr, Johannesburg, South Africa
[4] Univ Witwatersrand, Johannesburg, South Africa
[5] Hosp Clin San Carlos, Madrid, Spain
[6] Hosp 12 Octubre, E-28041 Madrid, Spain
[7] Inst Salah Azaiz, Tunis, Tunisia
[8] Inst Rech Pierre Fabre, Boulogne, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2004年 / 22卷 / 14期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
542
引用
收藏
页码：13S / 13S
页数：1
相关论文
共 50 条
  • [31] Phase I/II study of ixabepilone plus capecitabine in anthracycline-pretreated/resistant and taxane-resistant metastatic breast cancer
    Bunnell, Craig
    Vahdat, Linda
    Schwartzberg, Lee
    Gralow, Julie
    Klimovsky, Judith
    Poulart, Valerie
    Peck, Ronald
    Thomas, Eva
    CLINICAL BREAST CANCER, 2008, 8 (03) : 234 - 241
  • [32] Influence of age on the pharmacokinetics of i.v. vinflunine: Results of a phase I trial in elderly cancer patients
    Tourani, J. M.
    Mourey, L.
    Servent, V.
    Nguyen, T.
    Ravaud, A.
    Girre, V.
    Favrel, S.
    Pinel, M. C.
    Isambert, N.
    JOURNAL OF GERIATRIC ONCOLOGY, 2012, 3 (01) : 41 - 48
  • [33] A phase I-II study of gemcitabine and vinorelbine as second line treatment of patients with metastatic breast cancer.
    Fanelli, M
    Morabito, A
    Filipelli, G
    Vitale, S
    Palmeri, S
    De Bella, MT
    Gilberti, S
    Ferraù, F
    Massida, B
    Cascinu, S
    Catalano, V
    Gasparini, G
    ANNALS OF ONCOLOGY, 2000, 11 : 35 - 35
  • [34] Vinorelbine and fluorouracil plus leucovorin combination (ViFL) in patients with anthracycline and taxane-pretreated metastatic breast cancer: a phase II study
    Oliva, Cristiano
    Bergnolo, Paola
    Ingui, Manuela
    Bianco, Lavinia
    Pochettino, Paolo
    Cutin, Simona Chiado
    Boglione, Antonella
    Dal Canton, Orietta
    Garetto, Ferdinando
    Comandone, Alessandro
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2010, 136 (03) : 411 - 417
  • [35] A multicentre dose-escalating study of cabazitaxel (XRP6258) in combination with capecitabine in patients with metastatic breast cancer progressing after anthracycline and taxane treatment: A phase I/II study
    Villanueva, C.
    Awada, A.
    Campone, M.
    Machiels, J. P.
    Besse, T.
    Magherini, E.
    Dubin, F.
    Semiond, D.
    Pivot, X.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (07) : 1037 - 1045
  • [36] Gefitinib in Combination with Gemcitabine and Vinorelbine in Patients with Metastatic Breast Cancer Pre-treated with Taxane and Anthracycline Chemotherapy: A Phase I/II Trial
    Gioulbasanis, Ioannis
    Saridaki, Zacharenia
    Kalykaki, Antonia
    Vamvakas, Lambros
    Kalbakis, Kostas
    Ignatiadis, Michail
    Amarantidis, Kyriakos
    Kakolyris, Stylianos
    Georgoulias, Vassilis
    Mavroudis, Dimitris
    ANTICANCER RESEARCH, 2008, 28 (5B) : 3019 - 3025
  • [37] Pemetrexed in patients with locally advanced or metastatic breast cancer who had received previous anthracycline and taxane treatment: Phase II study
    Llombart-Cussac, Antonio
    Theodoulou, Maria
    Rowland, Kendrith
    Clark, Romnee S.
    Nakamura, Takashi
    Carrasco, Eva
    Cruciani, Giorgio
    CLINICAL BREAST CANCER, 2006, 7 (05) : 380 - 385
  • [38] Vinorelbine and fluorouracil plus leucovorin combination (ViFL) in patients with anthracycline and taxane-pretreated metastatic breast cancer: a phase II study
    Cristiano Oliva
    Paola Bergnolo
    Manuela Inguì
    Lavinia Bianco
    Paolo Pochettino
    Simona Chiadò Cutin
    Antonella Boglione
    Orietta Dal Canton
    Ferdinando Garetto
    Alessandro Comandone
    Journal of Cancer Research and Clinical Oncology, 2010, 136 : 411 - 417
  • [39] Phase II study of oxaliplatin and fluorouracil in taxane- and anthracycline-pretreated breast cancer patients
    Zelek, L
    Cottu, P
    Tubiana-Hulin, M
    Vannetzel, JM
    Chollet, P
    Misset, JL
    Chouaki, N
    Marty, M
    Gamelin, E
    Culine, S
    Dieras, V
    Mackenzie, S
    Spielmann, M
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (10) : 2551 - 2558
  • [40] Phase II study of intravenous vinflunine after failure of first-line vinorelbine based regimen for advanced breast cancer
    Blasinska-Morawiec, Maria
    Tubiana-Mathieu, Nicole
    Fougeray, Ronan
    Pinel, Marie-Claire
    Bougnoux, Philippe
    BREAST, 2013, 22 (01): : 58 - 63
12345